Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-24-031592
Filing Date
2024-08-13
Accepted
2024-08-13 16:01:16
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 4109
  Complete submission text file 0001493152-24-031592.txt   5656
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1651 NORTH BEVERLY DRIVE BEVERLY HILLS CA 90210
Business Address
Niklas Victoria Ninon Olivia (Reporting) CIK: 0002012250 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41934 | Film No.: 241201215